Crossover Health Funding: $292M Raised, Series D (2021)
Crossover Health has raised $292M in total funding. Latest round: Series D. Backed by Deerfield Management, Norwest Venture Partners, Avidity Partners.
Crossover Health funding overview
Crossover Health has raised $292M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in March 2021. The round record for Crossover Health runs through 2021; nothing later has been disclosed. Investors on record include Deerfield Management, Norwest Venture Partners, Avidity Partners, Foresite Capital, Irving Investors, OrbiMed and 3 others. 9 distinct backers are named across the disclosed rounds.
Crossover Health has raised $292M in total disclosed funding across the rounds on record.
Who has invested in Crossover Health?
Deerfield Management, Norwest Venture Partners, Avidity Partners, Foresite Capital, Irving Investors, OrbiMed are named among the investors backing Crossover Health.
What was the latest Crossover Health funding round?
The most recent disclosed round is a Series D, announced in March 2021.
Where is Crossover Health based?
No headquarters location is disclosed for Crossover Health.
When did Crossover Health last raise?
The last disclosed Crossover Health round closed in March 2021 at Series D.
We update the Crossover Health record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
